Does Turk Builder Max Actually Work?
Keywords:
Sports, Biology, Muscle hypertrophy, Supplement, TurkesteroneAbstract
Turk Builder Max is marketed as a leading turkesterone supplement due to its verified Ajuga turkestanica sourcing and third-party testing. It contains 10 mg of turkesterone per capsule, alongside other ecdysteroids and Rhodiola heterodonta extract, claimed to enhance muscle growth and performance. While some studies suggest anabolic potential, scientific evidence remains inconclusive. Label inconsistencies in turkesterone supplements highlight the need for independent testing. Though Turk Builder Max meets its ingredient claims, its true efficacy and safety require confirmation through large-scale, placebo-controlled human trials.
References
Greg Doucette (2025). Derek, This Is Between Us Now || Gorilla Mind Exposed. YouTube Video. [Online]. Available at: https://www.youtube.com/watch?v=Mzm_5_9K6fo [Accessed: 18 February 2025]
Backman, I. (2024). The FDA’s Proposed Ruling on Lab Tests Could Have Unintended Consequences. [online] Yale School of Medicine. Available at: https://medicine.yale.edu/news-article/the-fdas-proposed-ruling-on-lab-tests-could-have-unintended-consequences/ [Accessed: 18 February 2025]
HTLT Supplements. (2025). Turk Builder Max. [Online] Available at: https://www.htltsupps.com/products/turk-builder [Accessed: 18 February 2025]
Webmd.com. (2022). ECDYSTEROIDS: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews. [online] Available at: https://www.webmd.com/vitamins/ai/ingredientmono-1075/ecdysteroids [Accessed: 18 February 2025]
Tang, Y., Mo, Y., Xin D., Zeng, L., Yue, Z. & Xu, C. (2020). β-ecdysterone alleviates osteoarthritis by activating autophagy in chondrocytes through regulating PI3K/AKT/mTOR signal pathway. American journal of translational research, 12(11), pp. 7174-7186. PMID: 33312358; PMCID: PMC7724317. Available at: https://pubmed.ncbi.nlm.nih.gov/33312358/ [Accessed: 18 February 2025]
Dinan, L., Bourne, P., Whiting, P., Tsitsekli, A., Saatov, Z., Dhadialla, T.S., Hormann, R.E., Lafont, R. & Coll, J. (2003). Synthesis and biological activities of turkesterone 11α-acyl derivatives. Journal of Insect Science, 3(1). DOI: 10.1093/jis/3.1.6
Harris, D.R., Chapman-Lopez, T., Machek, S.B., Forsse, J.S., Sulak, T. & Funderburk, L.K. (2024). The Effects of Multiple Acute Turkesterone Doses on Indirect Measures of Hypertrophy and Metabolic Measures: A Preliminary Investigation. Muscles, 3(4), pp. 364–375. DOI: 10.3390/muscles3040031
PubChem (2025). Turkesterone. [online] Nih.gov. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Turkesterone [Accessed: 18 February 2025]
Syrov, V.N. (2000). Comparative experimental investigation of the anabolic activity of phytoecdysteroids and steranabols. Pharmaceutical Chemistry Journal, 34(4), pp. 193–197. DOI: 10.1007/bf02524596
Todorova, V., Ivanova, S., Chakarov, D., Kraev, K. & Ivanov, K. (2024). Ecdysterone and Turkesterone—Compounds with Prominent Potential in Sport and Healthy Nutrition. Nutrients, 16(9), p.1382. DOI: 10.3390/nu16091382
Isenmann, E., Ambrosio, G., Joseph, J.F., Mazzarino, M., de la Torre, X., Zimmer, P., Kazlauskas, R., Goebel, C., Botrè, F., Diel, P. and Parr, M.K. (2019). Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans. Archives of Toxicology, 93(7), pp. 1807–1816. DOI: 10.1007/s00204-019-02490-x
Todorova, V., Ivanova, S., Chakarov, D., Kraev, K. & Ivanov, K. (2024). Ecdysterone and Turkesterone—Compounds with Prominent Potential in Sport and Healthy Nutrition. Nutrients, 16(9), pp. 1382–1382. DOI: 10.3390/nu16091382
World Anti Doping Agency. (2023). Ecdysteroids as non-conventional anabolic agents: Pharmacodynamics, pharmacokinetics, and detection of ecdysterone. [online] Available at: https://www.wada-ama.org/en/resources/scientific-research/ecdysteroids-non-conventional-anabolic-agents-pharmacodynamics [Accessed: 18 February 2025]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Joey Sacarello
This work is licensed under a Creative Commons Attribution 4.0 International License.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. All content is licensed under a Creative Commons Attribution 4.0 International licence (CC-BY 4.0).
